AGEN earnings call for the period ending March 31, 2019.
News & Analysis: Agenus
Surprise! This retailer and lesser-known biotechnology company could be potential multibaggers.
AGEN earnings call for the period ending December 31, 2018.
These biopharmaceutical startups have been losing their investors' money for decades.
Agenus' stock crushed it last month. Here's why.
Eli Lilly's acquisition of Loxo Oncology lit a fire underneath the cancer immunotherapy company today.
The Super Bowl of biotech kicked off early for these companies.
Biotech was a popular sector today. Find out why.
The Bill & Melinda Gates Foundation helped to kick-start a manufacturing partnership for the small-cap biopharma.
These three biotech stocks could prove to be outstanding bargains for long-term investors.